Austar Lifesciences
Austar Lifesciences, a prominent player in the biotechnology sector, is headquartered in China (CN) and operates extensively across Asia and beyond. Founded in 2001, the company has established itself as a leader in the development of innovative biopharmaceuticals and healthcare solutions. Austar Lifesciences focuses on core areas such as drug discovery, development, and manufacturing, offering unique products that cater to unmet medical needs. With a commitment to quality and innovation, the company has achieved significant milestones, including partnerships with leading research institutions and successful product launches. Recognised for its contributions to the industry, Austar Lifesciences continues to strengthen its market position through cutting-edge research and a robust portfolio of services, making it a trusted name in the life sciences arena.
DitchCarbon Score
How does Austar Lifesciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Austar Lifesciences's score of 9 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Austar Lifesciences's reported carbon emissions
In 2023, Austar Lifesciences reported total carbon emissions of approximately 3,146,740 kg CO2e. This figure includes 73,490 kg CO2e from Scope 1 emissions, 2,001,370 kg CO2e from Scope 2 emissions, and 1,071,880 kg CO2e from Scope 3 emissions. Comparatively, in 2022, the company emitted about 1,915,640 kg CO2e, with Scope 1 at 38,940 kg CO2e, Scope 2 at 1,296,120 kg CO2e, and Scope 3 at 580,580 kg CO2e. This indicates a significant increase in total emissions from 2022 to 2023. In 2021, Austar's emissions were approximately 2,616,670 kg CO2e, with Scope 1 emissions at 32,110 kg CO2e, Scope 2 at 1,522,090 kg CO2e, and Scope 3 at 1,062,470 kg CO2e. The 2020 emissions were about 1,971,400 kg CO2e, comprising 41,400 kg CO2e from Scope 1, 1,121,100 kg CO2e from Scope 2, and 808,900 kg CO2e from Scope 3. Despite these figures, there are currently no documented reduction targets or climate pledges from Austar Lifesciences, indicating a potential area for improvement in their climate commitments. The company operates within a context where many organisations are increasingly setting science-based targets to reduce their carbon footprints, highlighting the importance of establishing clear reduction initiatives.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 41,400 | 00,000 | 00,000 | 00,000 |
| Scope 2 | 1,121,100 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 808,900 | 0,000,000 | 000,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Austar Lifesciences is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
